supplemented with 4 MM L-glutamine (GIBCO) 1.2% Penicillin-Streptomycin (Grand Island Biological Co .), and 20% heat-inactivated human serum. These flasks are incubated for 6 days in a 37°C, 95% air, and 5% C02 humid atmosphere, after which all cells are harvested and resuspended in final medium after washing once . All cell populations obtained by this method are referred to as CTLs even when no cytotoxic activity is demonstrated .
TARGETS AND BLOCKERS . At the same time that sensitization cultures are established, 5-30 x 106 lymphocytes are cultured in upright 50-ml tissue culture flasks containing 10-20 ml final medium . On day 6, 5-10 x 106 of these cells are labeled with "Cr as described previously (7), and resuspended at 1 x 105 radiolabeled cells/ml . The remaining unlabeled target cells are resuspended at varying concentrations and will be referred to as "blockers."
STANDARD "Cr-RELEASE ASSAY. Cytotoxicity assays are performed in 10 x 75 mm glass test tubes (Kimble Div., American Hospital Supply Corp ., Evanston, Ill.) by adding 0.1 ml of "Crlabeled target cells (1 x 10°cells) to 0.2 ml of CTL suspensions of varying concentrations . These are centrifuged at 150g for 5 min and then incubated in a 37°C, 5% C0 2 humid atmosphere for 4 h. Iced Medium 199 (1 .7 ml) is then added to stop the reaction and resuspend all cells. Tubes are spun at 600g for 10 min, and the "Cr containing supernates are decanted into glass tubes and counted for 5'Cr content in a gamma counter (Packard Instrument Co ., Inc., Downers Grove, Ill.) . "Cr-release data (mean counts per minute of triplicates ± SD) are expressed as percent cytotoxicity : % cytotoxicity = (exp . -SR) x 100 (max . -SR) where (SR) is the "Cr released spontaneously during 4 h by 1 x 10 4 labeled target cells alone ; max. is the "Cr released by 1 x 10°target cells lysed by detergent ; and exp. is the "Cr released by targets in the presence of CTLs . In CML studies of 53 different target cell preparations, the "Cr released by detergent has averaged 87 .2% of the total "Cr incorporated into the target cells, while the spontaneous release value has averaged 11 .1% of the total. This CML method sensitively detects cytotoxic activity directed at target cells to which responding lymphocytes have been sensitized . Cytotoxicity by two CTLs per target averaged 29 .5 ± 13 .5%, and in every combination of unrelated individuals tested, the killing by one CTL per target has been significantly greater than zero . In contrast, the "autokilling" observed by specifically sensitized CTLs tested at ratios of 10 or more per autologous target cell has averaged -0 .1 x 1 .2%.
CML-BLOCKING STUDIES. Specific CML blocking is performed by adding 0.2 ml of "blocker" cell suspension to each tube before the addition of CTLs . Analysis of "Cr data obtained from these blocking experiments will be discussed in the Results section.
Proliferative Studies . Mixed lymphocyte cultures (MLC) are performed by the method of Hartzman et al . (18) in final medium (described above) .
HL-A SD Typing . Serological detection of HL-A SD specificities was kindly performed by Dr .
Rudolf Wank using a modifed two-stage microcytotoxicity assay (19) . Testing was performed with at least 120 separate alloantisera which detect eleven alleles of the LA locus and 14 alleles of the Four locus. Due to lack of antisera, alleles of the third SD locus (AJ) have not been identified for these studies (20) .
Results and Discussion
Magnitude of "Cross-Killing ." Extensive human CML studies have correlated the magnitude of cytotoxicity on third-party target cells unrelated to the initial MLC-stimulating cells with the number of shared serologically detected (SD) antigens (8, 12) . If individuals B and C are picked at random, or share no SD antigens by serological criteria, previous reports have found no or low levels of significant cross-killing of C targets by CTLs from an AB,, culture (4, 9, 10) . Using the present CML method, the cross-killing has often been remarkably high, even when the specific sensitizing and third-party cells have no shared or cross-reacting SD antigens (14) .
In the experiment presented in Table I , CTLs mediate significant cytotoxicity on third-party targets bearing no serologically detectable cross-reactivities with the sensitizing cell donor. Each of the cross-killing combinations demonstrate that "cross-reactivities" not detectable by current serological methods can be identified by in vitro-sensitized CTLs ; the biological significance of these crossreactivities remains unclear. For example, the destruction of X targets by CTLs from the ZW.(ZW ./*X) mixed culture does not prove the existence of antigenic determinants shared by X and W that are recognized by Z, even though this relationship is often assumed. Several other specific and nonspecific mechanisms of CML cross-killing are possible ; these have been tested experimentally using the CML-blocking method .
Antigen-Specific Blocking of CML . The amount of cytotoxicity observed using this and most other CML assays is roughly proportional to the log of the CTL to target (K/T) ratio. This ratio is usually diminished by decreasing the number of CTLs while the number of "Cr-labeled targets is fixed. If the number of CTLs and target cells were fixed and the K/T ratio was decreased by the addition of unlabeled target cells, one would also predict a decrease in the percent cytotoxicity . This is the rationale behind the CML-blocking method (15) (16) (17) .
In the absence of CTLs, the blockers alone cause little or no variation from the SR value. This allows all 5'Cr release data to be calculated with the SR corresponding to 0% killing, even in the presence of blockers . In Table II , any inhibition of CML caused by the autologous L blockers must be due to steric effects (i .e, nonspecific physical interference with the interaction between CTLs and labeled targets) . In every combination tested the specific Q blockers inhibited the cytotoxicity to a greater degree than the L blockers, thereby demonstrating antigen-specific blocking .
Two separate approaches toward the quantitation of blocking data are presented . The percent "specific blocking", given in column inhibited by the same number of specific Q blockers, thereby reflecting the extent of antigen-specific blocking. These values may not accurately represent the magnitude of CML inhibition since percent cytotoxicity is not linearly proportional to the number of CTLs. For this reason we have also presented CML-blocking data by a second method, (columns B and C). In this case a "CTL potency" value is calculated (21) . This value reflects the number of specifically sensitized, but unblocked CTLs that would yield the same percent cytotoxicity as the blocked combination. For example, the potency of 50 x 10' CTLs in the presence of 50 x 104 L or Q blocking cells is 17 x 10' and 2 .6 x 10', respectively. Comparing these last two values demonstrates that 50 x 104 Q blocker cells inhibit 85% of the CTLs that were active in the presence of 50 x 104 L blockers . Blocking Analysis of Cross-Killing Specificity . Monolayer adsorption studies of CTLs have proven the existence of distinct antigen-reactive cytotoxic cell populations (22) (23) (24) . This finding, together with the absence of nonspecific 10 autokilling in this CML system, suggests that all cytotoxicity, including crosskilling, may be mediated by antigen-specific subpopulations of CTLs . There are at least two separate mechanisms by which CTLs reactive to antigens on thirdparty target cells could be generated in a CML-sensitization culture . NONSPECIFIC ALLOREACTIVE ACTIVATION. Activation of A responder cells by B.-stimulating cells has been shown to induce most of the CTL precursors from individual A that recognize Bm to differentiate into CTLs specifically cytotoxic for B. In addition, this activation mechanism may nonspecifically induce differentiation of a small fraction of other CTL precursor populations that are reactive to CML antigens not present on B ; some CTLs able to recognize antigens present on C targets but not on B, may be activated and therefore cause cross-killing on C targets.
SPECIFIC ANTIGEN-DEPENDENT ACTIVATION . Activation of A responder cells by Bm stimulators may induce only the A cells that are B reactive to become cytotoxic, leaving "dormant" all cytotoxic precursors not able to recognize antigens on B target cells . The observed killing of C targets by CTLs from an AB . MLC would result from recognition of antigenic determinants present on C that are also present on B.
Although previous CML reports have assumed that CML cross-killing demonstrates shared antigens, both of the above possibilities must be considered ; the mechanism of "nonspecific alloreactive activation" may be particularly relevant to those cases of significant CML cross-killing in the absence of shared or cross-reacting serologically detectible specificities (25, 26) .
These two mechanisms have been tested by blocking studies of CML crosskilling; in all cases the results have supported the second mechanism. One such experiment using lymphocytes obtained from three randomly selected unrelated donors is presented in Fig. 1 . The specific cytotoxicity mediated by CTLs from an AB . culture on B targets is inhibited from 28 .1 to 9.5% cytotoxicity by the addition of B blockers, while the same CTLs on B targets are inhibited to a lesser extent by third-party blockers from individual C, 17 .5% cytotoxicity . In contrast, the cross-killing on C targets is inhibited to the same degree by B and C blockers . This suggests that all the antigens AB m recognizes on the C targets are present on B blockers and were present on the initial B;stimulating cells. If any of the cross-killing on C targets had been due to nonspecific alloreactive activation there should have been CTLs from the AB m culture reactive only to C and thereby subject to blocking by C but not B . In such an experiment reciprocal specificity studies are crucial to prove that the observed result is actually due to antigen recognition rather than differential steric effects; as seen in Fig. 1 , the equivalent result is obtained in the reciprocal combinations .
Selective Blocking of Cytotoxic Subpopulations . Experiments using the above protocol prove that cross-killing of AB,/*C is not mediated by a subpopulation of nonspecifically activated CTLs reactive only to C and not B. However these same experiments by themselves cannot prove that cross-killing of C targets results from the recognition of antigens on the C cells that were also recognized on Bm in the initial AB . sensitization culture. It could still be argued that the observed inhibition of AB m/*C by B blockers has no relation to the recognition of shared target antigens . The unlabeled B target cells may block AB m /*C via some mechanism related to the presence of Bm as the specific stimulator, and independent of target antigens present on C. This possibility is ruled out by experiments in which reactivity to multiple antigens can be selectively blocked ; CTLs simultaneously stimulated by Em and Fm (Table III) are effectively blocked only by E blockers on E targets, and only by F blockers on F targets .
In total, these experiments demonstrate that CTLs are generated in vitro via the mechanism of "specific antigen-dependent activation," and that all CML cross-killing may result from recognition of shared antigens. These data also suggest that stimulation with several antigenic determinants, whether on two different allogeneic cells or possibly just on one stimulating cell, induces the differentiation of different cytotoxic populations for each determinant : these individual populations may specifically kill or be blocked only by cells bearing that single antigenic determinant.
CML Blocking is Controlled by the MHC . In the above studies, blocking of specific killing (i .e., AB m/*B) by unrelated third-party blocking populations has never been as effective as that caused by the specific blocker, suggesting the absence of at least some specific target antigens from the third-party cells . However a population of third-party cells bearing all the antigens recognized on the specific target would be expected to block as well as the specific blocker . Because CML reactivity is directed primarily against antigens controlled by the MHC, it is likely that cells from any individual sharing the same MHC recognized on the stimulating cells should block equivalently to the specific blockers . In Fig . 2 , individuals J and K are HL-A LD and SD identical siblings, H is a haplo-identical sibling differing by a maternal MHC, and M is their mother . In this experiment, some CTLs are derived from cultures in which responder and stimulator are haplo-identical so that any kinship member with the same stimulating MHC should block. This is observed on both H and J targets; KH,/*H is blocked similarly by H and M, while HJ,~*J is blocked by J, K, and M. On both of these targets, blockers from unrelated individual U cause no significant blocking compared to the blockers autologous to the CTLs. These U cells, however, were the only effective block of HU,~*U. Of importance is the significant killing of U targets by CTLs from the HJm culture . Individual U has no SD antigens that cross-react with the 1-17 haplotype recognized by sibling H on cells from J, K, or M . The cross-killing of U targets by these CTLs is inhibited significantly by blockers from K, M, and U (P < 0.005). The amount of blocking by family members K and M is not significantly different from the blocking by U (P > 0.05) . This last combination demonstrates three separate properties of CML cross-killing. First, cross-killing can be observed even when "full-house" typing reveals no cross-reacting SD determinants . Second, as shown in Fig. 1 and Table III , cross-killing results from the recognition of antigens shared by the stimulating cell and the thirdparty target cells. Third, these shared but serologically undetected antigens are controlled by the MHC .
Several lines of evidence have mapped the genetic control of CML detected antigens to the SD regions of the MHC, and have suggested that the serologically-detected and CML-detected antigens are genetically identical (8) (9) (10) (11) (12) (13) . If this is the case, detection of shared antigens by blocking of CML cross-killing and not by serological testing suggests that CTLs and antisera recognize different submolecular structures of the SD-gene products, or they recognize the same structures differently . In either case the CTL antigen receptor demonstrates different recognitive specificity than the antigen-binding site of the immunoglobulin (27) . Alternatively, the antigens recognized by CTLs might not be controlled by the SD loci, but instead by different closely linked loci within the SD regions . Under these conditions, the impressive correlation of SD antigen sharing with the magnitude of the CML reaction would be attributed to linkage disequilibrium . This would demonstrate a far greater recognitive dichotomy between immunoglobulins directed at SD antigens and in vitro sensitized CTLs directed at still some other target molecule .
Summary
The specificity of antigen recognition by in vitro sensitized human cytotoxic T lymphocytes (CTLs) has been studied using a sensitive cell-mediated lympholysis (CML) assay. Frequently, high levels of cytotoxicity are observed on thirdparty targets unrelated to sensitizing or responding cells; however, no cytotoxicity differing significantly from zero has been observed on targets autologous to the responding CTLs. This "cross-killing" of third-party target cells has been observed when stimulating and third-party cells bear no cross-reacting serologically defined (SD) antigens, thought to be the target antigens recognized by CTLs. CML-blocking studies, using unlabeled normal human lymphocytes to inhibit s'Cr release from radiolabeled target cells, have shown that cross-killing, even in the absence of shared SD determinants, results from CTLs recognizing antigens shared by the third-party targets and the initial stimulating population . Furthermore, these antigens have been mapped to the major histocompatibility complex (MHC) . The ability of human CTLs to specifically recognize MHC-controlled antigens not detected serologically suggests that SD antigens may be recognized differently by alloantisera and CTLs, or that MHC antigens other than SD may be the targets of CTLs in CML .
